I’m an ICU Doctor Who Treated a Critically Ill Hantavirus Patient. Here’s What Everyone Should Know.
This is why early care matters.
Reported by Women's Health Magazine.
A 14-year-old girl named Evie arrived at Cincinnati Children's emergency department in July 2022 and, within 24 hours, was on life support. Her lungs were failing. Her heart couldn't sustain blood pressure. Doctors scrambled to keep her alive — and for an entire week, they still didn't know why she was dying.
The answer, according to Women's Health Magazine, was hantavirus — a rare, rodent-transmitted illness that carries a mortality rate of up to 50 percent, per the World Health Organization. The disease is notoriously hard to diagnose because standard blood cultures come back negative, testing isn't fast, and it's geographically uncommon in many parts of the country. Evie's care team initially treated her for what they call "culture-negative sepsis." It was only after learning she had recently been in North Dakota — where hantavirus does occur — that physicians thought to test for it. By then, she'd already been on ECMO for days.
What ECMO Actually Is — and Why It Matters
ECMO, or extracorporeal membrane oxygenation, is essentially a heart-lung bypass machine: it pulls blood out of the body, oxygenates it, removes carbon dioxide, and pumps it back in. It's a last resort — and it's not available everywhere. Getting Evie connected to the machine required a 45-to-60-minute surgery, during which her heart stopped for nine minutes. She received chest compressions until her team could restart it. She spent five days on ECMO, then weeks more on a ventilator, then over a month total in the hospital. Without access to that machine, her ICU doctor said plainly: she would not have survived. ECMO carries serious risks — stroke, hemorrhage, clotting — and demands round-the-clock specialist monitoring. Many hospitals simply don't have it.
That access gap is the real crisis with hantavirus. Because the illness progresses so aggressively, patients can deteriorate too quickly to be safely transferred to a major medical center. If hantavirus is even a remote possibility, the recommendation is immediate evaluation and urgent discussion about transferring to an ECMO-capable facility — before the window closes. There are currently no antivirals for hantavirus. No targeted treatment exists. The only strategy is aggressive supportive care, and the only thing that determines who survives is how fast they reach the right level of it.
Evie recovered. Her family has acknowledged that geography — the sheer luck of being near a pediatric ECMO center when she got sick — saved her life. That's not a comforting footnote; it's an urgent reminder that with hantavirus, speed isn't just important — it's everything.
Read the original at Women's Health Magazine.
